新毕业生药物安全准备:澳大利亚的横截面和纵向定性研究研究
Ella Ottrey1, Charlotte E Rees1,2, Kayley M Lyons3,4
1Monash Centre for Scholarship in Health Education (MCSHE), Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Frontiers in medicine
|March 2, 2026
概括
新毕业的医疗保健毕业生经常觉得对药物安全性没有准备,因为错误而经历了严重的情感痛苦. 建议侧重于改善药物管理准备的教育和支持.
科学领域:
- 医疗保健教育卫生保健教育
- 患者安全研究的研究.
- 定性研究方法的方法.
背景情况:
- 药物管理错误很常见,影响患者的安全,特别是在新的医疗保健毕业生中.
- 需要评估和加强新获得资格的专业人员的药物安全准备.
- 这项研究的重点是护理,药房和医学毕业生.
研究的目的:
- 为了探索新毕业生的药物安全准备.
- 了解与药物管理相关的挑战和情绪影响.
- 为更好的毕业生准备提供教育策略的信息.
主要方法:
- 长度定性研究 (LQR) 与澳大利亚的26名医疗保健最后一年的学生.
- 通过入门面试,纵向音频日记和退出面试收集的数据超过12周的工作时间.
- 分析采用基于团队的框架,对成绩单和信件进行分析.
主要成果:
- 大多数参与者报告说,他们对药物安全性没有做好准备,特别是在制定治疗计划时.
- 药物错误叙述强调了毕业生和其他人犯下的错误,具有显著的负面情绪影响.
- 虽然队列准备度随着时间的推移而增加,但个人经验各不相同,显示稳定性或变化.
结论:
- 为教育工作者提供基于证据的建议,以改善学生和新毕业生的药物安全学习.
- 支持安全药物管理的情感方面的策略至关重要.
- 建议进行进一步的长度定性研究,持续时间延长.
相关概念视频
Pharmaceutical Poisoning: Potential Scenarios
47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
Bioavailability Study Design: Healthy Subjects Versus Patients
192
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
192
Preclinical Development: Overview
6.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.2K


